BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Wednesday, June 17, 2026
Home » Topics » Briefs » In the clinic

In the clinic
In the clinic RSS Feed RSS

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Angle, Braintale.
Read More

In the clinic for Jan. 21, 2022

Jan. 21, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Arecor, Biovie, Calcimedica, Elpiscience, Hinova, Hutchmed, Idorsia, Infant Bacterial, Intelgenx, Merck, Oncolytic, Revelation, Seres, Sorrento, Vigeo, Xilio, Zealand.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Neovasc.
Read More

In the clinic for Jan. 20, 2022

Jan. 20, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cstone, Eisai, Eqrx, Essa, Immix, Immvira, Lynk, Recce, Revive, Sanofi, Vyne.


Read More

In the clinic for Jan. 19, 2022

Jan. 19, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Guardant, Kaia, Pops! Diabetes Care, Theranica.
Read More

In the clinic for Jan. 19, 2022

Jan. 19, 2022

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alligator, Anges, Bluerock, Cstone, Eliem, Georges, HDT, Hookipa, I-Mab, Innocare, Inversago, Ionis, Keymed, Moleculin, Rafael, Reneuron, Reservlogix, Revelation, Roche, Sciwind, Sensorion, UCB, Vaccitech, Vasomune.


Read More

In the clinic for Jan. 11-17, 2022

Jan. 18, 2022
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Alar, Ascletis, Bharat Biotech International, Cansino, Cara, Hutchmed, I-Mab, Lianbio, Maruishi, Molecular Partners, Novartis, Ocugen, Pharmamar, Quantum Leap Healthcare Collaborative, Redhill, Zai Lab.
Read More

In the clinic for Jan. 18, 2022

Jan. 18, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Achiko, Angle, Biology Works, Moleculight, Neovasc.
Read More

In the clinic for Jan. 18, 2022

Jan. 18, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Cantargia, Corvus, Pieris.
Read More

In the clinic for Jan. 14, 2022

Jan. 14, 2022
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adagene, AI, Ascletis, First Wave, Gritstone, GSK, Imcyse, Oncopeptides, On Target, Redhill, Rhythm, Rubius, Spago, Tempus.
Read More
Previous 1 2 … 205 206 207 208 209 210 211 212 213 … 326 327 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 17, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • CAR T and red blood cells

    Viva in vivo! At EHA, in vivo CAR T data continues to impress

    BioWorld
    Treatment with first-generation CAR T cells regularly sent patients to the intensive care unit. Now, investigators are envisioning a future where CAR T treatment...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing